A detailed history of Powell Investment Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Powell Investment Advisors, LLC holds 639 shares of LLY stock, worth $595,867. This represents 0.27% of its overall portfolio holdings.

Number of Shares
639
Previous 639 -0.0%
Holding current value
$595,867
Previous $372,000 33.6%
% of portfolio
0.27%
Previous 0.21%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 31, 2024

BUY
$525.19 - $619.13 $10,503 - $12,382
20 Added 3.23%
639 $372,000
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $77,493 - $90,295
-241 Reduced 28.02%
619 $226,000
Q1 2022

May 09, 2022

BUY
$234.69 - $291.66 $2,816 - $3,499
12 Added 1.42%
860 $246,000
Q4 2021

Jan 14, 2022

BUY
$224.85 - $279.04 $190,672 - $236,625
848 New
848 $234,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $886B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Powell Investment Advisors, LLC Portfolio

Follow Powell Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Powell Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Powell Investment Advisors, LLC with notifications on news.